CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 15 enrolled
Drug / intervention
10,600 nm fractional carbon dioxide laser systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00585286
NCT00585286Phase 2Completed
CompareCT.gov

Evaluation of a Novel Fractional Resurfacing Device for the Treatment of Acne Scarring

University of California, Irvine·interventional·Posted Jan 3, 2008·Updated Jan 15, 2014

In Brief

A Phase 2 clinical trial evaluating 10,600 nm fractional carbon dioxide laser system for Acne and Scar. Completed, enrolled 15 participants across 1 site.

Detailed Summary

The purpose of this research study is to evaluate the safety and effectiveness of a new investigational laser device for treatment of acne scarring, for improvement in the appearance of surface texture and topography (recessed or uneven surfaces).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne, Scar
CountriesUnited States
CollaboratorsReliant Technologies, Inc. Mountain View, CA, University of Minnesota

Timeline

Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 3, 2008
Enrollment StartMar 1, 2007
Primary CompletionJul 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 18.5 years ago

Interventions

10,600 nm fractional carbon dioxide laser systemdevice

1-3 laser treatments using 20-100 millijoules (mJ) with 100-400 microscopic treatment zones (MTZ)/cm2 per pass and total density of 600-1200 MTZ/cm2